Oracle shares are approaching a critical juncture. As the stock price has recently shown weakness, a colossal infrastructure deal taking shape behind the scenes could redefine the company’s role in powering the next generation of artificial intelligence. Market experts point to a potential upside nearing 90%, yet investor apprehension over the associated capital expenditure remains palpable.
A Pivotal Earnings Report on the Horizon
The immediate focus for investors is Oracle’s upcoming quarterly results. The financial report for the second quarter, scheduled for release on Monday, December 8, is widely anticipated. A strong performance or, crucially, an official confirmation of a landmark partnership could serve as the catalyst to narrow the significant gap between the current share price and analyst price targets. Presently, the equity trades around €174.56, a level substantially below its previous peaks.
The $38 Billion OpenAI Partnership
Central to Oracle’s strategic shift is a reported financing package of staggering proportions. The company, in collaboration with Vantage Data Centers, is reportedly in negotiations to invest approximately $38 billion to construct new data centers specifically designed for OpenAI, the creator of ChatGPT. This initiative would rank among the largest infrastructure commitments in the industry’s history.
The move underscores a deliberate and aggressive strategy to transform Oracle’s identity. The goal is to shed its legacy image as a traditional software enterprise and establish itself as an indispensable backbone for generative AI. Should this agreement be finalized, the capital infusion would supplement the already-secured $30 billion in funding provided by partners such as SoftBank.
Should investors sell immediately? Or is it worth buying Oracle?
Analysts Identify Significant Undervaluation
Despite these ambitious plans, the market’s valuation has left analysts from Deutsche Bank and HSBC perplexed. Both institutions have reaffirmed their price targets exceeding $375 per share. Their core thesis is that the burgeoning revenue stream from the OpenAI business is currently being assigned virtually no value by the market.
Experts Brad Zelnick of Deutsche Bank and Stephen Bersey of HSBC argue that even excluding potential income from this partnership, Oracle’s core business justifies a higher valuation. They see the present stock level as a clear mispricing that fails to account for the company’s long-term growth drivers.
Investor Jitters Over “AI Waste”
The disconnect between analyst optimism and market sentiment stems from concerns over capital allocation. A key hesitation among investors revolves around the fear of “AI waste” and the specter of exploding investment costs. The potential need for Oracle to take on substantial debt to fund the $38 billion project has prompted worries about balance sheet strain among more conservative market participants.
This caution persists even though Oracle’s stock, with a forward P/E ratio just under 30, appears moderately valued both from a historical perspective and when compared to other high-flying AI-centric companies. The coming days will determine whether the bullish outlook prevails, hinging on concrete financial results and strategic clarity from the company’s leadership.
Ad
Oracle Stock: Buy or Sell?! New Oracle Analysis from December 3 delivers the answer:
The latest Oracle figures speak for themselves: Urgent action needed for Oracle investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 3.
Oracle: Buy or sell? Read more here...









